CURRENT BLADDER TUMOR TESTS: DOES THEIR PROJECTED UTILITY FULFILL CLINICAL NECESSITY?

Cancer statistics, 1998

1998 • 2,407 citations

TELOMERE LENGTH REGULATION

1996 • 1,010 citations

Superficial Bladder Cancer: Progression and Recurrence

1983 • 947 citations

Biology and Management of Bladder Cancer

1990 • 430 citations

COMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER

1999 • 329 citations

PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE

1998 • 285 citations

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1998 • 238 citations

URINARY HYALURONIC ACID AND HYALURONIDASE: MARKERS FOR BLADDER CANCER DETECTION AND EVALUATION OF GRADE

2000 • 221 citations

NATURAL HISTORY OF SUPERFICIAL BLADDER CANCER

1992 • 214 citations

EXCLUSION CRITERIA ENHANCE THE SPECIFICITY AND POSITIVE PREDICTIVE VALUE OF NMP22* AND BTA STAT [dagger]

1999 • 203 citations

IMMUNOCYT ¹ : A NEW TOOL FOR DETECTING TRANSITIONAL CELL CANCER OF THE URINARY TRACT

1999 • 187 citations

CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?

1998 • 177 citations

A Community Study of Bladder Cancer Screening by the Detection of Occult Urinary Bleeding

1992 • 165 citations

Home Screening for Hematuria: Results of a Multi-Clinic Study

1992 • 159 citations

Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity

1998 • 155 citations

Strategies for Asymptomatic Microscopic Hematuria: A Prospective Study of 1,034 Patients

1990 • 147 citations

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

1997 • 139 citations

NONINVASIVE DETECTION OF BLADDER CANCER WITH THE BTA STAT TEST

1999 • 130 citations

RAPID PROTECTION OF BLADDER CANCER: A COMPARATIVE STUDY OF POINT OF CARE TESTS

1997 • 129 citations

Comparison of the BTA <i>stat</i><sup>TM</sup> Test with Voided Urine Cytology and Bladder Wash Cytology in the Diagnosis and Monitoring of Bladder Cancer

1999 • 127 citations

Bladder cancer: state-of-the-art care

1998 • 125 citations

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

1997 • 122 citations

Hematuria Home Screening: Repeat Testing Results

1995 • 98 citations

Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values

1999 • 90 citations

Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program

1996 • 84 citations

Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder

1998 • 79 citations

Bladder Wash Cytology, Quantitative Cytology, and the Qualitative BTA Test in Patients with Superficial Bladder Cancer

1998 • 72 citations

DETECTION OF CIRCULATING UROPLAKIN-POSITIVE CELLS IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER

1999 • 68 citations

Non-occupational risk factors for cancer of the lower urinary tract in Germany.

1999 • 68 citations

Comparison of the Nuclear Matrix Protein 22 with Voided Urine Cytology and BTA stat Test in the Diagnosis of Transitional Cell Carcinoma of the Bladder

1999 • 67 citations

Molecular Detection of Cancer Cells by Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNAs

1998 • 66 citations

Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria

1999 • 62 citations

Utility of the BTA stat test kit for bladder cancer screening

1999 • 60 citations

Cohort mortality study of 57,000 painters and other union members: a 15 year update

1999 • 59 citations

CYTOKERATIN 20: A NEW MARKER FOR EARLY DETECTION OF BLADDER CELL CARCINOMA

1998 • 56 citations

Quantitative Detection of Human Complement Factor H-Related Protein in Transitional Cell Carcinoma of the Urinary Bladder

1999 • 56 citations

BTA <i>stat</i> and BTA TRAK: A Comparative Evaluation of Urine Testing for the Diagnosis of Transitional Cell Carcinoma of the Bladder

1999 • 54 citations

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): Multicenter trial comparing bacille calmette-guérin and interferon-alpha

1997 • 54 citations

Evaluation of Urinary Level of NMP22 as a Diagnostic Marker for Stage pTa-pT1 Bladder Cancer: Comparison with Urinary Cytology and BTA Test

1999 • 53 citations

Cancer incidence and cause specific mortality among workers in two Norwegian aluminum reduction plants

2000 • 52 citations

Tobacco, occupation and non-transitional-cell carcinoma of the bladder: An international case-control study

1999 • 51 citations

Semi‐quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma

1998 • 49 citations

Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients

1998 • 48 citations

Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

1999 • 47 citations

Urinary NMP22<sup>TM</sup> and Karyometry in the Diagnosis and Follow-Up of Patients with Superficial Bladder Cancer

1998 • 46 citations

Management of patients with rising prostate-specific antigen after radical prostatectomy

2000 • 44 citations

Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

1998 • 43 citations

Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice

1999 • 38 citations

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

2000 • 38 citations

Further study of fibrinogen degradation products in bladder cancer detection

1978 • 32 citations

Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients

1994 • 31 citations

The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder

1997 • 27 citations

Diagnostic Value of Voided Urine and Bladder Barbotage Cytology in Detecting Transitional Cell Carcinoma of the Urinary Tract

1999 • 25 citations

THE RELATIONSHIP BETWEEN SERIAL MEASUREMENTS OF THE LEVEL OF A BLADDER TUMOR ASSOCIATED ANTIGEN AND THE POTENTIAL FOR RECURRENCE

1999 • 25 citations

Up-Front Intravesical Chemotherapy for Low Stage, Low Grade Recurrent Bladder Cancer

1996 • 24 citations

Bladder Cancer Incidence in Arylamine Workers

1996 • 23 citations

Urothelial Differentiation and Bladder Cancer

1999 • 22 citations

Use of diagnostic categories in urinary cytology in comparison with the bladder tumour antigen (BTA) test in bladder cancer patients.

1999 • 18 citations

Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study

1996 • 16 citations

Bladder cancer

1999 • 15 citations

Markers of bladder cancer State of the art

2000 • 10 citations